Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: Parkinson disease,on-off phenomena in (Click to remove) Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease Neurol 68:1108-1115, Pahwa,R.,et al, 2007 A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001 Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study JNNP 66:436-441, Pinter,M.M.,et al, 1999 Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa Neurol 43:1981-1984, Lieberman,A.,et al, 1993 Dopamine Agonist Treatment of Fluctuating Parkinsonisn Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992 Subcutaneous Apomorphine in the Treatment of Parkinson's Disease JNNP 53:96-101, Frankel,J.P.,et al, 1990 Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990 Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations Lancet 1:403-406, Stibe,C.M.H.,et al, 1988 Pergolide Mesylate & Idiopathic Parkinson Disease Neurol 32:1175-1179, Tanner,C.M.,et al, 1982 Further Studies with Pergolide in Parkinson Disease Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982 Bromocriptine in Parkinson Disease:Further Studies Neurol 29:363-369, Lieberman,A.N.,et al, 1979 Showing articles 0 to 11 of 11